BPC-157 is a sequence of 15 amino acids. Amino acids are just the basic building blocks that make up proteins. What makes this specific sequence interesting is that it is a stable version of a peptide naturally found in human gastric juice, which is the acid and liquid found in your stomach.
Where did it come from?
This compound is often called a stable gastric pentadecapeptide. In plain English, that means it is a small protein segment that stays steady even in the harsh environment of your stomach. Because it is native to the human body, scientists have been poking at it for a while now to see what else it might do.
Here is how researchers think it works inside the body:
- Angiogenesis: This is a fancy way of saying it helps promote the growth of new blood vessels.
- Nitric Oxide Modulation: It helps manage nitric oxide, a molecule that helps your blood vessels relax and open up.
- Fibroblast Support: It tells the receptors on fibroblasts—cells that help form connective tissue—to wake up and get to work.
- Tight Junctions: It helps enhance proteins that act like glue between cells to keep things sealed tight.
Is the hype backed by science?
If you look at the raw numbers, there are over 100 preclinical studies on BPC-157. However, scientists are still working on this one—turns out the human body is complicated. Who knew?
The vast majority of those 100+ studies were done on animals, not humans. Most of the research is also concentrated at a single institution, the University of Zagreb. While a Phase II trial for Ulcerative Colitis (UC) was completed, other human trials have hit roadblocks. For example, a Phase I safety trial with 42 healthy volunteers was canceled in 2016, and the results were never submitted.
There is also a registered Phase II trial for repairing acute hamstring muscle strains, but the completion date is currently listed as TBD.
What do the regulators say?
Right now, BPC-157 has a Grade: C+ for evidence. It is not FDA-approved. In fact, as of March 2026, it is listed as a Category 2 substance. This means the FDA sees it as having a significant safety risk, and it is not eligible for routine compounding.
The government has issued warning letters to companies like Tailor Made Compounding and Predator Nutrition regarding this compound. The main concerns cited by regulators include:
- Immunogenicity: The risk that your immune system might have an unwanted reaction to it.
- Lack of safety data: We simply do not have enough long-term human information yet.
- Unregulated sourcing: Buying this from random sources is a major safety concern.
Taking the next step
This is a great one to bring up with your doctor. Because BPC-157 is not FDA-approved and faces specific regulatory restrictions, you want a professional to help you navigate the facts. You can find peptide-experienced physicians in our Find a Doctor directory who can explain what the current research means for you.
If you are searching for peptide therapy near me, make sure you are looking for providers who prioritize safety data over internet trends.
This content is sourced exclusively from TruthTides clinical reference data and does not constitute medical advice.
Referenced Peptides
This content was generated from TruthTides clinical reference data. It does not constitute medical advice. Always consult a qualified healthcare provider.